34Defining mode of action is vital for both developing new drugs and predicting 35 potential resistance mechanisms. African trypanosome pentamidine and 36 melarsoprol sensitivity is predominantly mediated by aquaglyceroporin 2 (TbAQP2), a 37 channel associated with water/glycerol transport. TbAQP2 is expressed at the flagellar 38 pocket membrane and chimerisation with TbAQP3 renders parasites resistant to both 39 drugs. Two models for how TbAQP2 mediates pentamidine sensitivity have emerged; 40 that TbAQP2 mediates pentamidine translocation or via binding to TbAQP2, with 41 subsequent endocytosis, but trafficking and regulation of TbAQPs is uncharacterised. 42We demonstrate that TbAQP2 is organised as a high order complex, is ubiquitylated 43 and transported to the lysosome. Unexpectedly, mutation of potential ubiquitin 44 conjugation sites, i.e. cytoplasmic lysine residues, reduced folding and tetramerization 45 efficiency and triggered ER retention. Moreover, TbAQP2/TbAQP3 chimerisation also 46 leads to impaired oligomerisation, mislocalisation, and increased turnover. These data 47suggest that TbAQP2 stability is highly sensitive to mutation and contributes towards 48 emergence of drug resistance. 49 50 Human African trypanosomiasis (HAT) is a neglected tropical disease affecting 52 sub-Saharan countries [1-4]. HAT progresses by two stages: a haemolymphatic 53 stage, in which the parasite successfully colonises the bloodstream, lymphatics, skin, 54 adipose tissue and organs and a meningoencephalic stage characterised by the 55 emergence of parasites in the central nervous system (CNS) [2,5]. Several drugs are 56 used to treat HAT; currently suramin and pentamidine are the drugs of choice for 57 treatment of the haemolymphatic stage of T. brucei rhodesiense and T. brucei 58 gambiense infections respectively, whereas melarsoprol, eflornithine or combined 59 nifurtimox-eflornithine (NECT) therapy are recommended for the meningoencephalic 60 stage [6,7]. 61 Two new drugs, fexinidazole and acoziborole, recently completed clinical trials 62 and opened a new front in HAT chemotherapy [8,9]. Drug development, successful 63 public health initiatives and active case-monitoring programs have all contributed to 64 the anticipated eradication of gambiense HAT as a major public health problem in the 65 coming decade [10]. However, vigilance and understanding of drug mechanisms and 66 possible resistance pathways remain essential to maintain this situation, and 67rhodesiense HAT cannot be eliminated in this way as it is highly zoonotic [11]. 68Genome-wide RNAi screens identified a number of genes associated with 69 pentamidine sensitivity that, together with evidence from melarsoprol-pentamidine 70 cross-resistance (MPXR), identified aquaglyceroporin 2 as the primary determinant for 71 drug-uptake [12,13], alongside lesser roles for the TbAT1/P2 aminopurine transporter 72 and the Low Affinity Pentamidine transporter LAPT1 [14]. 73 Aquaglyceroporins (AQPs) are an ancient family of multi-pass membrane 74 proteins, containing b...